Merck signposts a new strategy for patent owners in India
US pharmaceutical company Merck & Co – known as Merck Sharp & Dohme (MSD) outside of North America – has entered into an alliance with generic drug maker Cipla to co-market one of its antiretroviral treatments in India, Bloomberg reports. The…
To read more
Register for limited access
Register to receive our weekly newsletter and access two of our subscriber-only articles per month.
Register now
Subscribe and start reading now
Subscribe for unlimited access to articles, in-depth analysis and research from the IAM experts.
Subscribe now